ARTICLE | Clinical News
GI-5005: Completed Phase II enrollment
May 26, 2008 7:00 AM UTC
GlobeImmune completed enrollment of 120 patients with chronic HCV genotype 1 infection in an open-label, international Phase II trial evaluating pegylated interferon plus ribavirin with or without sub...